Advertisement

Topics

Pfizer quarterly revenue slips 2 percent

02:59 EDT 1 Aug 2017 | Reuters

(Reuters) - Pfizer Inc reported a nearly 2 percent drop in quarterly revenue on Tuesday, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar.

Original Article: Pfizer quarterly revenue slips 2 percent

NEXT ARTICLE

More From BioPortfolio on "Pfizer quarterly revenue slips 2 percent"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...